APA

Gille B., De Schaepdryver M., Goossens J., Dedeene L., De Vocht J., Oldoni E., Goris A., Van Den Bosch L., Depreitere B., Claeys K. G., Tournoy J., Van Damme P. & Poesen K. (20200819). Serum neurofilament light chain levels as a marker of upper motor neuron degeneration in patients with Amyotrophic Lateral Sclerosis. : Neuropathology and applied neurobiology.

Chicago

Gille B, De Schaepdryver M, Goossens J, Dedeene L, De Vocht J, Oldoni E, Goris A, Van Den Bosch L, Depreitere B, Claeys K G, Tournoy J, Van Damme P and Poesen K. 20200819. Serum neurofilament light chain levels as a marker of upper motor neuron degeneration in patients with Amyotrophic Lateral Sclerosis. : Neuropathology and applied neurobiology.

Harvard

Gille B., De Schaepdryver M., Goossens J., Dedeene L., De Vocht J., Oldoni E., Goris A., Van Den Bosch L., Depreitere B., Claeys K. G., Tournoy J., Van Damme P. and Poesen K. (20200819). Serum neurofilament light chain levels as a marker of upper motor neuron degeneration in patients with Amyotrophic Lateral Sclerosis. : Neuropathology and applied neurobiology.

MLA

Gille B, De Schaepdryver M, Goossens J, Dedeene L, De Vocht J, Oldoni E, Goris A, Van Den Bosch L, Depreitere B, Claeys K G, Tournoy J, Van Damme P and Poesen K. Serum neurofilament light chain levels as a marker of upper motor neuron degeneration in patients with Amyotrophic Lateral Sclerosis. : Neuropathology and applied neurobiology. 20200819.